| 摘要 |
The present invention provides an oral use formulation intended for prevention and treatment of inflammatory changes in digestive tract, wherein the formulation contains mucoadhesive biologically compatible hydrophilic polymer comprising: - at least one type of structural units A being selected from the group consisting of units derived from acrylic and methacrylic acids and salts thereof, hydroxyalkylacrylates and methacrylates, hydroxyalkylacrylamides and methacrylamides, N,N-dialkylaminoalkylacrylates and methacrylates, N,N-dialkylaminoalkylacrylamides and methacrylamides, N-vinyl-2-pyrrolidone and mixtures thereof; - at least one type of structural units B being selected from the group consisting of units derived from hydroxy terminated polyoxyethylene acrylates and methacrylates, alkyloxy terminated polyoxyethylene acrylates and methacrylates, hydroxy terminated polyoxyethylene acrylamides and methacrylamides, alkyloxy terminated polyoxyethylene acrylamides and methacrylamides, and mixtures thereof; and – at least one type of structural units C derived from sterically protected amines. |
